Nuhra Tech — White Paper
Nuhra Tech — White Paper

The Healthcare Cost Problem

Why the most expensive healthcare system in the world is structurally designed to crush the smallest providers serving the hardest patients.
March 2026 · nuhratech.com · 24 primary sources

The Numbers

MetricValueSource
Total US healthcare spending (2024)$5.3 trillion ($15,474/capita, 18% of GDP)CMS1
Medicare + Medicaid combined$2.05 trillion (39% of NHE)CMS1
Medicare hospital reimbursement$0.83 per $1.00 of costAHA2
Medicare + Medicaid hospital shortfall$130 billion/yearAHA2
Hospitals with negative Medicare margins67%AHA2
Medicare FFS hospital margin (2023)-13%MedPAC3
Administrative spending (2017)$812 billion (34.2% of NHE)Annals of Internal Medicine4
Canada administrative spending17% of NHEWoolhandler et al.4
Healthcare waste from admin complexity$265.6 billion/yrJAMA5
Top 5% of patients, share of spending49.7%AHRQ6
Top 10% of patients, share of spending65.9%AHRQ6

The Structural Problem

A small fraction of the population drives the majority of healthcare costs. The top 10% of patients account for nearly two-thirds of all spending.6 These patients are disproportionately served by Medicare and Medicaid.

Providers lose money serving them. Two-thirds of hospitals operate at a loss on Medicare patients.2 The combined government shortfall is $130 billion per year. These are not charitable organizations absorbing losses out of mission — they are businesses dealing with a loss leader that represents their largest patient segment.

The system stays solvent through cost-shifting. Hospitals charge private insurers significantly more than Medicare rates to subsidize government patient losses. MedPAC data confirms this: hospital all-payer margin is +6.4% despite a -13% Medicare margin.3 Private insurance is the cross-subsidy.

This optimization pressure — maximize private payer revenue to cover government losses — drives coding complexity, documentation requirements, and administrative overhead, which drives up costs for everyone.

The Administrative Tax

34.2%
of every US healthcare dollar goes to administration — more than double Canada's 17%.
Woolhandler et al., Annals of Internal Medicine, 2020

That was $812 billion in 2017.4 Adjusted for the growth to $5.3T total spending, the current figure is well over $1 trillion annually.

A 2014 eight-nation study found US hospital administrative costs were 25.3% of total hospital expenditures, compared to approximately 12% in Canada and Scotland.11 Reducing US hospital admin to Canadian levels would save over $150 billion per year in hospital spending alone.

JAMA estimated $265.6 billion per year in pure administrative waste — not total admin, just the excess.5 It is the single largest category of waste in US healthcare, ahead of clinical waste, fraud, and overtreatment.

Complexity as Cost Control

The insurance system built complexity as a cost control mechanism. Prior authorizations, denial workflows, appeals processes, credentialing requirements, payer-specific formularies and rules — these are speedbumps designed to create attrition. A denied claim that never gets appealed is money the payer keeps.

MetricValueSource
Prior auth requests per physician per week39AMA7
Staff hours/week spent on prior auth per physician13 hoursAMA7
Physicians reporting PA increases burnout89%AMA7
Physicians reporting PA delays care93%AMA7
PA-related serious adverse events27% of physicians reportAMA7

Denial Rates by Payer Type

ProgramPrior Auth Denial RateSource
Medicaid Managed Care (avg)12.5% (range: 6-34% by MCO)HHS OIG8
Medicare Advantage (2024)7.7%KFF9
ACA Marketplace (all claims, 2023)19% (range: 1-54%)KFF10

The Attrition Strategy Works

MetricValueSource
Medicare Advantage denials never appealed88%KFF9
ACA Marketplace denials never appealed99%KFF10
Appeals that succeed when actually filed (MA)82%KFF9
Key Finding

When providers actually appeal, they win 82% of the time. The denials are not clinically justified — they are friction. And the friction works because 88-99% of denied claims are never challenged.

This is by design. Every denied claim requires a person to read the denial, pull the chart, write the appeal, fax it, follow up. The speedbumps work because humans are slow and expensive to throw at the problem.

The Arms Race

  1. Providers lose money on government patients (-13% Medicare margin)
  2. They need to maximize private payer revenue to stay solvent
  3. This means aggressive coding, more documentation, more admin staff
  4. Payers respond with more managed care, more prior auth, more denials
  5. Providers hire more admin to fight denials (34.2% of spending is admin)
  6. Costs go up, premiums go up
  7. Employers push for more cost controls
  8. Back to step 4

The only guaranteed winners are the administrative infrastructure itself.

Who Gets Crushed

Large health systems can brute-force this with headcount — dedicated rev cycle teams, coding departments, compliance officers. They have built their own maze-running infrastructure.

Small to midsized organizations cannot. A 5-provider behavioral health clinic, a rural hospital, a small SUD treatment center — they face the same complexity as a 500-bed system without the resources to absorb it. The administrative burden is disproportionately destructive at this scale.

Uwe Reinhardt (Princeton health economist) documented a telling comparison: a McGill-affiliated hospital complex managing 39,000 inpatients per year with 12 billing staff, versus an equivalent US hospital requiring 800-900 billing staff for the same volume.12

The Contradiction in the Rules

Payers deny claims and hide behind "the provider didn't follow the process." Most of the time they are technically right — because the process is deliberately byzantine and providers miss steps. The payer wins by default.

But the rules themselves are often contradictory. Policies don't match actual denial behavior. Stated criteria conflict with applied criteria. The system relies on providers not having the bandwidth to notice, document, or challenge these contradictions at scale.

82%
of Medicare Advantage appeals are overturned. If the denials were clinically sound, that number would be inverted.
KFF, January 2025

Regulatory Capture: The Third Cost Vector

Underpayment and denial friction are two mechanisms that extract value from providers. The third is regulatory capture — the process by which the entities being regulated shape the rules to serve their own interests.

The healthcare industry is the largest lobbying sector in the United States. In 2023, the health sector spent $739 million on lobbying. Pharma and health products accounted for $385.6 million; health insurance contributed $129.3 million. Among the top spenders in 2024: PhRMA ($24M), AHA ($21.3M), AMA ($18.1M), BCBS ($49.5M), UnitedHealth Group ($16.6M), and AdvaMed ($4.13M).13

The organizations shaping this framework — FDA, ONC, AHA, AdvaMed, AMIA — are not disinterested parties. Several are trade groups that actively lobby for their members' commercial interests. The framework they are shaping will determine who can sell AI into healthcare and at what compliance cost.

The Revolving Door

A 2023 Health Affairs study — the first to systematically quantify personnel movement between HHS and industry — found that 15% of HHS appointees entered from private industry, but 32% exited to industry at end of tenure. At CMS specifically, more than half of appointees departed for private industry. At the CDC, 54% left for industry.14

At the FDA, a 2018 Science investigation found 11 of 16 medical examiners who worked on 28 drug approvals and subsequently left the agency now work for or consult for the companies they regulated.15 A Stanford Law & Policy Review article documented the legal framework for how this creates both conscious and unconscious bias in regulatory decisions.16

The pattern is consistent: regulators build expertise on the public payroll, then monetize that expertise — and their relationships — in the private sector. The rules they write while in government reflect the institutional knowledge of where they expect to work next.

Advisory Committee Conflicts

A GAO audit found that over half of FDA advisory committee meetings had at least one member with a financial conflict of interest. Across 83 meetings examined, 16% of all participants had conflicts.17 A separate JAMA study of 221 FDA Drug Advisory Committee meetings found 73% had at least one conflicted member and 28% of voting members had financial conflicts.18

The AMA's Relative Value Scale Update Committee (the RUC) — a private committee of specialty physicians — recommends Medicare payment rates to CMS. CMS accepts approximately 90% of RUC recommendations. The RUC is not a federal advisory committee and is not subject to FACA transparency requirements.3

The Compliance Cost Moat

$8M vs $5.1M
Annual compliance costs for independent hospitals vs. system-affiliated hospitals — a 57% premium for operating outside a large system.
AHA Regulatory Overload Report, 2017

The AHA's own 2017 Regulatory Overload Report quantified the burden: $38.6 billion per year in national compliance costs. The average community hospital spends $7.6 million annually on regulatory compliance, consuming 59 FTEs — over 25% of which are clinical staff pulled from patient care.19 Rural hospitals spend 18% more of total expenses on administrative salaries than urban hospitals.19, 20

Every new regulatory framework — including the proposed Clinical AI Regulatory Framework expected in late 2026 — adds to this fixed cost. Risk-based oversight requires risk assessment staff. Post-deployment monitoring requires monitoring infrastructure. Modernized privacy requires privacy officers and audits. Clear accountability requires legal review and documentation.

Large systems amortize these costs across thousands of beds and billions in revenue. A 5-provider behavioral health clinic eats them whole.

The AI Regulation Play

The organizations shaping clinical AI rules are positioning to benefit from the complexity they create:

These are not neutral recommendations. Each position maps to the commercial interests of the organization's membership. The resulting framework will function as a barrier to entry — not because the rules are wrong in principle, but because the cost of compliance is a fixed overhead that scales inversely with organizational size.

The Three-Vector Model

VectorMechanismWho Benefits
UnderpaymentCMS pays below cost (-13% Medicare margin, $130B shortfall)Government (lower spending)
Denial FrictionPayers weaponize process complexity (82% of appeals win, 88% never filed)Insurance companies
Regulatory CaptureIndustry-influenced rules raise compliance floor ($8M/yr independent vs $5.1M system)Large health systems, device manufacturers, compliance industry

All three disproportionately crush small providers serving the hardest populations. All three depend on complexity being expensive to navigate. All three are vulnerable to the same intervention: making the maze free to run.

The Human Cost: Where It All Lands

Every vector described above — underpayment, denial friction, regulatory capture — ultimately terminates at the same place: the patient. The person who is already sick.

Providers absorb losses, fight denials, and navigate regulatory complexity. But they do not eat those costs permanently. They pass them forward through higher prices, reduced access, longer waits, and narrower networks. The final recipient is always the consumer.

100 million
Americans carry medical debt. It is the leading cause of personal bankruptcy in the United States.
KFF Health Care Debt Survey, 2022; Consumer Financial Protection Bureau, 2022

The average American family now spends over $24,000 per year on health insurance premiums and out-of-pocket costs combined.24 Deductibles have risen 10x faster than wages over the past two decades. The "coverage" millions of Americans carry would not survive contact with a serious diagnosis.

Sick and Fighting

The cruelest feature of the system is its timing. Denials, prior authorizations, formulary exceptions, appeals — all of these administrative battles happen while the patient is in active medical crisis. A cancer patient waits for chemotherapy authorization. A behavioral health patient loses medication continuity during a prior auth delay. A parent navigates an appeal while caring for a hospitalized child.

93% of physicians report that prior authorization delays necessary care.7 27% report that prior authorization has led to a serious adverse event for a patient.7 These are not abstract statistics. They are people who got worse — or died — while paperwork moved through a queue.

The Quiet Cruelty

The system asks the sickest people in the country to become their own claims administrators. Navigate the appeal. Call the insurance company. Get the reference number. Follow up in 7-10 business days. Do this while you are in treatment, in pain, or in crisis. The maze is hard enough for a healthy person with a law degree. For a patient mid-treatment, it is functionally impassable.

The Behavioral Health Amplifier

In behavioral health — where Nuhra Tech operates — the consumer burden is amplified by the nature of the conditions being treated. Substance use disorder, depression, anxiety, PTSD: these are conditions that directly impair the executive function required to navigate complex administrative systems. The system demands the most from the people least equipped to give it.

SUD patients cycling through treatment face insurance barriers at every transition. New provider, new authorization, new formulary. Continuity of care breaks not because of clinical failure but because the administrative connective tissue does not exist. Every gap is an opportunity for relapse. Every relapse is a new admission, a new set of claims, a new round of denials — and the cycle restarts.

The financial toll compounds the clinical one. Patients in early recovery who receive unexpected medical bills or lose coverage face a stress trigger that directly undermines their treatment. The system designed to help them is actively working against their recovery.

The Opportunity

Providers are leaving billions on the table — not because they delivered the wrong care, but because the administrative process is too expensive to execute perfectly. Every missed appeal is revenue owed. Every delayed authorization is a patient who deteriorates. Every compliance gap is margin lost to paperwork.

If you could make perfect compliance the default — every form filled correctly, every authorization submitted on time, every eligible claim followed through to collection — providers recover the revenue they have already earned and patients receive the care they have already been prescribed.

The math is straightforward. 82% of appeals succeed when filed. 88% are never filed. That is not a clinical problem. It is an operational one. Solve the operations and the money follows — money that goes directly to provider margins, clinical capacity, and patient access.

The question is: can you make the maze free to run?

Why Nuhra Tech

Nuhra Tech exists to make complexity costless for the providers and patients stuck in it. That is not a tagline — it is an engineering thesis. Every administrative process that burns clinician time and delays patient care is a process that should run itself.

The technical vision comes from Ask the Human (askthehuman.com), the AI-accelerated builder studio behind Nuhra's product development. But selling into healthcare at scale requires more than engineering. It requires BD, compliance, and clinical expertise. Nuhra Tech is the vehicle that brings those functions together.

We are already in the maze. Orbiit Recovery — our first product — attacks the care coordination problem. SUD patients bouncing between providers, lost referrals, redundant assessments, no continuity. The system is complex because nobody built the connective tissue. Orbiit is that connective tissue.

The administrative burden is the same problem, different maze. Providers serving the most expensive patient populations are losing money on every government patient, then burning a third of their revenue navigating processes that should be automated. The revenue is already earned. It just needs to be collected.

We start in behavioral health. It is where we already operate, where the Medicaid patient concentration is highest, and where providers are smallest and most under-resourced. Better margins for providers. Better continuity for patients. The playbook scales from there.

Better provider margins. Better patient outcomes. Less time in the maze, more time in the clinic.

Sources

  1. CMS National Health Expenditure Data, NHE Fact Sheet (2024 data). Centers for Medicare & Medicaid Services. cms.gov
  2. 2024 Costs of Caring Report (2023 data). American Hospital Association. aha.org
  3. March 2025 Report to the Congress: Medicare Payment Policy, Chapter 3. MedPAC. medpac.gov
  4. Woolhandler S, Campbell T, Himmelstein DU. "Health Care Administrative Costs in the United States and Canada, 2017." Annals of Internal Medicine. Jan 2020. DOI: 10.7326/M19-2818
  5. Shrank WH, Rogstad TL, Parekh N. "Waste in the US Health Care System." JAMA. Oct 2019. jamanetwork.com
  6. MEPS Statistical Brief #560. AHRQ. March 2025. ahrq.gov
  7. 2024 AMA Prior Authorization Physician Survey. AMA. ama-assn.org
  8. "High Rates of Prior Authorization Denials..." HHS OIG. OEI-09-19-00350. July 2023. oig.hhs.gov
  9. "Medicare Advantage Insurers Made Nearly 53 Million Prior Authorization Determinations in 2024." KFF. Jan 2025. kff.org
  10. "HealthCare.gov Insurers Denied Nearly 1 in 5 In-Network Claims in 2023." KFF. Jan 2025. kff.org
  11. Himmelstein DU, et al. "A Comparison of Hospital Administrative Costs in Eight Nations." Health Affairs. Sep 2014. healthaffairs.org
  12. Reinhardt UE. "Priced Out." Princeton University Press, 2019. press.princeton.edu
  13. OpenSecrets: Health Sector Lobbying Data (2023-2024). opensecrets.org
  14. "The Revolving Door In Health Care Regulation." Health Affairs. 2023. healthaffairs.org
  15. Piller C. "Is FDA's revolving door open too wide?" Science. Jul 2018. science.org
  16. Karas L. "FDA's Revolving Door: Reckoning and Reform." Stanford Law & Policy Review. Vol. 34, No. 1. 2023. stanford.edu
  17. GAO-08-640: FDA Advisory Committees. GAO. Sep 2008. gao.gov
  18. Lurie P, et al. "Financial Conflict of Interest Disclosure and Voting Patterns at FDA Drug Advisory Committee Meetings." JAMA. pmc.ncbi.nlm.nih.gov
  19. Regulatory Overload Report. AHA. Nov 2017. aha.org
  20. Rural hospital administrative cost burden. PMC. pmc.ncbi.nlm.nih.gov
  21. AdvaMed AI Policy Roadmap. Advanced Medical Technology Association. March 2025. advamed.org
  22. AHA Response to OSTP Request on AI Policies in Health Care. American Hospital Association. October 2025. aha.org
  23. AMIA 2024 Policy Year-In-Review; AI Task Force. American Medical Informatics Association. 2025. amia.org
  24. 2024 Employer Health Benefits Survey. KFF. October 2024. kff.org